Skip to main content
. 2021 Aug 10;18(16):8431. doi: 10.3390/ijerph18168431

Table 3.

Etiology of the non-CF bronchiectasis patients.

Etiology, N, % Total Below-Threshold Cluster Above-Threshold Cluster
Post-infectious 343, 37.9% 113, 42% 230, 36.2%
 Tuberculosis 122, 13.5% 42, 15.6% 80, 12.6%
 Childhood infections 83, 9.2% 26, 9.6% 57, 9%
 Necrotizing pneumonia 29, 3.2% 6, 2.2% 23, 3.6%
 Non-tuberculous mycobacteria 10, 1.1% 3, 1.1% 7, 1.1%
 Fungal infections 4, 0.4% 2, 0.7% 2, 0.3%
 Others 658, 72.6% 191, 70.7% 467, 73.4%
COPD 103, 11.4% 34, 12.6% 69, 10.8%
Asthma 90, 9.9% 24, 8.9% 66, 10.4%
Hyperimmune response 3, 0.3% 1, 0.4% 2, 0.3%
Vasculitis 2, 0.2% 0 2, 0.3%
Systemic disorders 78, 8.6% 17, 6.3% 61, 9.6%
Immunodeficiencies 42, 4.6% 13, 4.8% 29, 4.6%
Inflammatory pneumonitis 21, 2.3% 7, 2.6% 14, 2.2%
Congenital malformations 9, 1% 1, 0.4% 8, 1.3%
Inflammatory bowel diseases 9, 1% 2, 0.7% 7, 1.1%
Obliterative bronchiolitis 6, 0.7% 3, 1.1% 3, 0.5%
Unknown etiology 166, 18.3% 45, 16.7% 121, 19.0%
Other etiologies 34, 3.8% 10, 3.7% 24, 3.8%

Absolute number of patients and percentage for each etiologic condition. Definitions of the abbreviations: N, number; %, percentage; COPD: chronic obstructive pulmonary disease.